Christopher Abbott
Plus aucun poste en cours
Fortune : 17 M $ au 31/03/2024
Profil
Christopher M.
Abbott was the Chairman-Emeritus and founder of Genetic Signatures Ltd.
Dr. Abbott is also the founder of Peplin Ltd., Maple-Brown Abbott Ltd.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
GENETIC SIGNATURES LTD.
20,59% | 28/08/2023 | 38 392 200 ( 20,59% ) | 17 M $ | 31/03/2024 |
Anciens postes connus de Christopher Abbott
| Sociétés | Poste | Fin |
|---|---|---|
Maple-Brown Abbott Ltd.
 Maple-Brown Abbott Ltd. Investment ManagersFinance Maple-Brown Abbott Ltd. (MBA) is an investment management firm headquartered in Sydney, Australia. The firm was founded by Robert Maple-Brown and Chris Abbott in 1984. They are a subsidiary of Maple-Brown Family Investments Pty Ltd. The firm offers Australian managed investment schemes, UCITS (Undertaking for Collective Investment in Transferable Securities) funds in a variety of currencies and discrete mandates to clients around the world. Their clients include superannuation funds, financial institutions, endowments, charities, family offices, financial advisers, wholesale investors and retail investors. MBA is a socially responsible investor and a signatory to the UN Principles for Responsible Investment (UNPRI). | Founder | - |
Peplin Ltd.
 Peplin Ltd. Pharmaceuticals: OtherHealth Technology Peplin Ltd. provides development and commercialisation of prescription human therapeutic products for the treatment of cancer. It also provides drug development process, clinical development and pre-clinical development services. It was was founded in 1998 and is located in Newstead, Australia | Founder | - |
| GENETIC SIGNATURES LIMITED | Founder | - |
Expériences
Fonctions occupées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| GENETIC SIGNATURES LIMITED | Commercial Services |
| Entreprise privées | 2 |
|---|---|
Peplin Ltd.
Peplin Ltd. Pharmaceuticals: OtherHealth Technology Peplin Ltd. provides development and commercialisation of prescription human therapeutic products for the treatment of cancer. It also provides drug development process, clinical development and pre-clinical development services. It was was founded in 1998 and is located in Newstead, Australia | Health Technology |
Maple-Brown Abbott Ltd.
Maple-Brown Abbott Ltd. Investment ManagersFinance Maple-Brown Abbott Ltd. (MBA) is an investment management firm headquartered in Sydney, Australia. The firm was founded by Robert Maple-Brown and Chris Abbott in 1984. They are a subsidiary of Maple-Brown Family Investments Pty Ltd. The firm offers Australian managed investment schemes, UCITS (Undertaking for Collective Investment in Transferable Securities) funds in a variety of currencies and discrete mandates to clients around the world. Their clients include superannuation funds, financial institutions, endowments, charities, family offices, financial advisers, wholesale investors and retail investors. MBA is a socially responsible investor and a signatory to the UN Principles for Responsible Investment (UNPRI). | Finance |
